https://simplecast.com Podcasts we created for industry supporters. en Mon, 25 Mar 2024 04:42:02 +0000 Mon, 25 Mar 2024 04:42:13 +0000 https://the-limbic-sponsored-podcasts.simplecast.com https://image.simplecastcdn.com/images/625cf068-4381-4a96-971a-7ccc5429c672/9804fb90-16ad-417c-a0fb-ddf7a201bbd7/3000x3000/thelimbic-mark-black.jpg?aid=rss_feed https://the-limbic-sponsored-podcasts.simplecast.com episodic Podcasts we created for industry supporters. The limbic no https://feeds.simplecast.com/xUS7fmw_ the limbic john@thelimbic.com 953895c3-90bb-4745-b423-618659a2e882 Mon, 25 Mar 2024 04:42:02 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/selinexor-in-relapsed-refractory-multiple-myeloma-international-experience-2LAdmBux Selinexor in relapsed/refractory multiple myeloma: international experience the limbic 00:25:11 no full 48 8505f0bf-75c4-4a49-964f-deb9719b8e06 Thu, 21 Mar 2024 13:17:23 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/after-pbs-changes-for-tpo-ras-in-itp-where-are-we-now-fxv81VaE After PBS changes for TPO-RAs in ITP: where are we now? the limbic 00:25:56 no full 47 4e69df36-f448-4691-8332-469bcf454fc9 Tue, 12 Mar 2024 06:00:05 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/managing-adults-with-x-linked-hypophosphataemia-ZGPGKial Managing adults with X-linked hypophosphataemia the limbic 00:19:28 no full 46 d15472c7-f011-4c79-83bf-cd304e978658 Wed, 7 Feb 2024 03:26:41 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/xadago-for-parkinsons-disease-australian-clinical-experience-3vpiYy3x Xadago for Parkinson’s disease: Australian clinical experience the limbic 00:20:47 no full 44 9834ee40-a359-4b4f-818c-eb3944496c7d Mon, 20 Nov 2023 12:56:00 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/perspectives-from-ims-2023-targeted-therapies-for-myeloma-pTFwuloI Perspectives from IMS 2023: Targeted and novel therapies for myeloma the limbic 00:16:00 no full 43 672984ec-9996-4c7b-ab86-64788fef0ec4 Mon, 20 Nov 2023 12:21:39 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/perspectives-from-ims-2023-immunotherapy-updates-_n4Z3IN7 Perspectives from IMS 2023: Immunotherapy updates the limbic 00:31:50 no full 42 64bcb1fc-e4a3-4c23-b43b-4bb6f9bfc994 Tue, 7 Nov 2023 03:02:58 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/clinical-pathway-for-coronary-atherosclerosis-in-smurf-less-patients-1C7PZG7O Clinical pathway for coronary atherosclerosis in SMuRF-less patients the limbic 00:22:53 no full 41 6eec29b2-43c2-40f4-9844-e9b9a68023b2 Mon, 30 Oct 2023 11:57:46 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/mylotarg-in-aml-dosing-schedules-NBF2XmHr Mylotarg in AML: Dosing schedules the limbic 00:21:19 no full 40 48cfd8a0-f1f1-418e-b96f-2db06352cf91 Mon, 30 Oct 2023 11:53:17 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/mylotarg-in-aml-adverse-event-management-iG97NCoY Mylotarg in AML: Adverse event management the limbic 00:15:27 no full 39 8fe81dfd-e566-4a96-b209-90dc1bb40aa2 Mon, 30 Oct 2023 11:46:53 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/mylotarg-in-aml-which-patients-are-suitable-for-treatment-ApOMAGgD Mylotarg in AML: Which patients are suitable for treatment? the limbic 00:26:55 no full 38 258923f3-8157-4ba1-94d9-a828b9b28a6b Thu, 26 Oct 2023 05:58:09 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/deucravacitinib-in-moderate-to-severe-plaque-psoriasis-expert-perspective-ofV7ZqBI Deucravacitinib in moderate-to-severe plaque psoriasis: expert perspective the limbic 00:21:08 no full 37 c175ce8c-1794-4ded-8ff9-5f7e68025f23 Thu, 24 Aug 2023 02:16:40 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/clinical-experience-with-drf-practical-tips-for-patient-management-PHXLBaeh Clinical experience with DRF – Practical tips for patient management the limbic 00:18:37 no full 36 6a14a305-8b3c-4d6b-bd43-9b9a6d33ac76 Fri, 18 Aug 2023 08:16:00 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/perspectives-on-the-current-status-of-r-r-all-management-rPsTK2kV Perspectives on the current status of r/r ALL management the limbic 00:28:50 no full 35 054ec8aa-bbf6-44e4-ace8-67be0ffe2756 Tue, 25 Jul 2023 01:40:38 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/epidyolex-for-lennox-gastaut-syndrome-clinical-perspectives-HvoX4Lwv Epidyolex for Lennox-Gastaut Syndrome: Clinical perspectives the limbic 00:35:36 no full 34 4c51be34-adf9-4a5f-ad1b-d137b4af8b8e Tue, 18 Jul 2023 03:35:05 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/zanubrutinib-in-cll-expert-perspectives-sY2rmTFq Zanubrutinib in CLL: Expert perspectives the limbic 00:16:59 no full 33 7deb7d6b-7d2a-4d9c-a0d8-20893a25cbda Thu, 15 Jun 2023 01:35:20 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/reflections-on-baricitinib-real-world-data-1iA24QXX Reflections on baricitinib real world data the limbic 00:20:15 no full 32 54cd3027-01ef-4911-8672-90a5c326f8e2 Wed, 31 May 2023 00:46:39 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/cardiovascular-health-in-the-covid-era-QuUMzRzX Cardiovascular health in the COVID era the limbic 00:24:26 no full 31 782f60b4-b13f-4da5-9475-c841b4476363 Mon, 8 May 2023 00:42:31 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/a-call-to-arms-for-biomarker-driven-care-in-severe-asthma-axcC_YZ_ Biomarker-driven management of eosinophilic asthma the limbic 00:23:44 no full 30 cb38dac2-8b4b-4c7c-9479-98b9f1edd42a Mon, 13 Feb 2023 07:18:01 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/the-potential-role-of-antibody-drug-conjugates-lmCHEqQG The potential role of antibody-drug conjugates the limbic 00:18:24 no full 29 3689a1a3-59e2-407e-a0f5-ab7c22b44faf Mon, 13 Feb 2023 06:34:12 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/place-in-therapy-of-currently-available-immune-checkpoint-inhibitors-w3T4VCyJ Place in therapy of currently available immune checkpoint inhibitors the limbic 00:20:07 no full 28 981ff1a3-4ad4-4fab-951b-bb7cbabea882 Thu, 9 Feb 2023 00:25:59 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/the-place-in-therapy-of-immune-checkpoint-inhibitors-Gr_Kuejb The place in therapy of immune checkpoint inhibitors the limbic 00:20:17 no full 26 b3eef643-56cb-4281-83e4-359f69fba536 Wed, 25 Jan 2023 05:22:52 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/tangible-steps-to-better-adherence-strategies-for-post-acs-secondary-prevention-cbjk1zrn-U7yX2JZ9 Tangible steps to better adherence strategies for post-ACS secondary prevention the limbic 00:11:47 no full 25 3793edc7-90eb-4d2a-b631-7086e8591f63 Mon, 23 Jan 2023 00:50:19 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/neuromodulation-as-a-treatment-option-for-drug-resistant-epilepsy-who-why-and-when-izRSBquO Neuromodulation as a treatment option for drug resistant epilepsy: who, why and when the limbic 00:18:46 no full 24 63145e35-00b2-4119-a31d-4e00adf547b6 Tue, 22 Nov 2022 15:33:06 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/nstemi-reassessing-the-treatment-risk-paradox-z_v0jVn3 NSTEMI: reassessing the treatment-risk paradox the limbic 00:26:52 no full 23 4f3b5df3-2ea0-4983-97a2-d8cd5e45c8cc Mon, 14 Nov 2022 04:30:26 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/immune-competence-in-cll-can-it-be-improved-d0gxe2a5 Immune competence in CLL - can it be improved? the limbic 00:23:37 no full 22 075dcd02-52f8-4aae-a04e-470aea80cdb9 Wed, 26 Oct 2022 05:26:51 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/vumerity-for-rrms-gi-tolerability-considerations-NvQxazBX Vumerity for RRMS: GI tolerability considerations the limbic 00:12:12 no full 21 459eef6a-db07-48fa-9229-e22a0167b99b Tue, 20 Sep 2022 08:05:26 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/wm-msag-guidelines-FfEP4JUF Updated guidance on the treatment of patients with Waldenström Macroglobulinaemia the limbic 00:16:05 no full 19 bc7d9fba-e077-4d81-9fb0-ef339e8c787a Mon, 19 Sep 2022 00:31:54 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ribociclib-in-advanced-breast-cancer-monaleesa-insights-5cn3Hmuz Ribociclib in advanced breast cancer: MONALEESA insights the limbic 00:18:40 no full 18 6820ce67-aabf-4568-ab22-8152d62a5483 Wed, 14 Sep 2022 08:19:40 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ep-2-clinical-insights-into-epidyolex-a-cannabis-based-antiseizure-medication-VCZAM_XZ EP 2: Clinical insights into Epidyolex: a cannabis-based antiseizure medication the limbic 00:28:55 no full 17 fc946f73-646e-4619-802a-4e88b2305eee Wed, 14 Sep 2022 08:17:11 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ep-1-clinical-insights-into-epidyolex-a-cannabis-based-antiseizure-medication-_IRspfnK EP 1: Clinical insights into Epidyolex: a cannabis-based antiseizure medication the limbic 00:23:30 no full 16 88433209-adab-46d9-b021-b37971cf06fe Wed, 7 Sep 2022 22:59:53 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ibrutinib-in-rr-mcl-insights-from-10-year-data-2iY5zh1R Ibrutinib in RR MCL: Insights from 10-year data the limbic 00:23:31 no full 15 2afb0281-1fc0-4453-9cd0-0901dedec009 Fri, 19 Aug 2022 00:34:35 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/tangible-steps-to-better-adherence-strategies-for-post-acs-secondary-prevention-UR9_95f8 Tangible steps to better adherence strategies for post-ACS secondary prevention the limbic 00:11:54 no full 14 a4ec689a-591e-4cc5-97a0-f1ecb378a8d3 Fri, 19 Aug 2022 00:32:08 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/dapt-who-when-and-for-how-long-FP_aWAoY DAPT: Who, when and for how long? the limbic 00:28:05 no full 13 545d25f6-f069-4c80-99bc-db6bb3473cfb Tue, 16 Aug 2022 00:27:30 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/treatment-considerations-for-crohns-disease-tk3iGOmq Treatment considerations for Crohn's disease the limbic 00:09:39 no full 12 c6723ba6-71f2-4e57-a2df-9811af63451a Tue, 16 Aug 2022 00:24:59 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/treat-to-target-in-crohns-disease-2T1r_xyo Treat-to-target in Crohn's disease the limbic 00:21:35 no full 11 b08ec743-7df0-41dd-87c3-5b0b3f96bf6d Thu, 28 Jul 2022 08:19:46 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/new-heart-failure-consensus-statement-what-you-need-to-know-4XXGtvhu New Heart Failure consensus statement: what you need to know the limbic 00:24:41 no full 10 9f287165-f284-4e9c-8190-6429207a2a0e Mon, 18 Jul 2022 05:08:27 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/part-two-pharmacotherapy-options-for-weight-loss-o1SlIfgp Part two: Pharmacotherapy options for weight loss the limbic 00:28:50 no full 9 2f90e950-e78a-4e82-962f-c38e5775fc50 Mon, 18 Jul 2022 05:06:14 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/clinical-approaches-to-weight-management-B5KMQcR_ Clinical approaches to weight management the limbic 00:24:12 no full 8 9c49fd64-2f4e-4e52-9e55-66e737bcd5cc Tue, 14 Jun 2022 04:17:04 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/options-for-lenalidomide-refractory-mm-patients-lessons-from-optimismm-287T_71_ Options for lenalidomide-refractory MM patients: Lessons from OPTIMISMM the limbic 00:21:00 no full 6 26fe3ed9-1885-44e2-964f-0381a2c41a2c Fri, 3 Jun 2022 04:12:33 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/what-is-the-urgency-post-acs-to-mitigate-risk-beyond-the-acute-emergency-and-whose-job-is-it-anyway-fZLGMGsh What is the urgency post-ACS to mitigate risk beyond the acute emergency, and whose job is it anyway? the limbic 00:17:46 In this podcast, A/Prof Karam Kostner speaks to practicing clinicians about best-practice approaches to post-ACS risk management. In this podcast, A/Prof Karam Kostner speaks to practicing clinicians about best-practice approaches to post-ACS risk management. no full 5 2b279668-2a08-4c48-ab48-9dd993e3fc4a Wed, 8 Dec 2021 21:38:37 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/waldenstrom-macroglobulinemia-Gw3Tuizo Waldenström macroglobulinemia the limbic 00:24:33 no full 4 bf566d80-f025-403d-a9c7-e99cd4c066f3 Mon, 29 Nov 2021 05:09:27 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/precision-oncology-in-hepatocellular-carcinoma-qS5IMiT4 Precision oncology in hepatocellular carcinoma the limbic 00:21:08 no full 3 4b9b22ca-f539-454f-8660-9d6166db866a Mon, 8 Nov 2021 05:00:23 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/precision-medicine-and-companion-diagnostics-for-oncologists-testing-reporting-and-actionability-KIkI5b_l Precision medicine and companion diagnostics for oncologists - testing, reporting and actionability the limbic 00:33:33 no full 2 120abb5b-9121-46aa-bd65-6e791ef9b51c Tue, 5 Oct 2021 09:39:13 +0000 john@thelimbic.com (the limbic) https://the-limbic-sponsored-podcasts.simplecast.com/episodes/cladribine-considerations-in-the-era-of-covid-19-nNTFh9Lw Cladribine considerations in the era of COVID-19 the limbic 00:50:19 no full 1